BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36652023)

  • 21. ASO Author Reflections: Preoperative Nutritional Care: The 'Cinderella' of Surgical Management in Patients with Pancreatic Cancer.
    Paiella S; Trestini I; Milella M; Salvia R
    Ann Surg Oncol; 2020 Dec; 27(13):5335-5336. PubMed ID: 32356267
    [No Abstract]   [Full Text] [Related]  

  • 22. Addressing racial/ethnic disparities in cancer clinical trials: Everyone has a role to play.
    Habr D; Ferdinand R
    Cancer; 2021 Sep; 127(18):3282-3289. PubMed ID: 33904590
    [No Abstract]   [Full Text] [Related]  

  • 23. ASO Author Reflections: Real Prevalence of Occult Cancer Cells in Peritoneal Lavage in Patients with Pancreatic Ductal Adenocarcinoma.
    Suenaga M; Fujii T
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):893-894. PubMed ID: 32812111
    [No Abstract]   [Full Text] [Related]  

  • 24. ASO Author Reflections: Identification of Prognostic Factors for Stage-III Pancreatic Ductal Adenocarcinoma patients.
    Chattopadhyay A; Wu CH; Tien YW; Lu TP
    Ann Surg Oncol; 2022 Mar; 29(3):1616-1617. PubMed ID: 34802101
    [No Abstract]   [Full Text] [Related]  

  • 25. ASO Author Reflections: The Challenge of Achieving High-Quality, Equitable Care for Pancreatic Cancer: Might Medicaid Expansion Be a Piece of the Puzzle?
    Fonseca AL; Johnston FM; Tran-Cao HS
    Ann Surg Oncol; 2022 Jan; 29(1):352-353. PubMed ID: 34448962
    [No Abstract]   [Full Text] [Related]  

  • 26. ASO Author Reflections: Expanding Guideline Concordant Care: The Time for a National Accreditation Program for Pancreatic Cancer is Now.
    Murimwa GZ; Meier J; Nehrubabu M; Khan S; Polanco PM
    Ann Surg Oncol; 2023 Jul; 30(7):4388-4389. PubMed ID: 36943526
    [No Abstract]   [Full Text] [Related]  

  • 27. ASO Author Reflections: Tackling Breast Cancer Disparities in Rural America: An Old Challenge in a New Decade.
    Obeng-Gyasi S; Haggstrom D
    Ann Surg Oncol; 2020 Jun; 27(6):1816-1817. PubMed ID: 32222860
    [No Abstract]   [Full Text] [Related]  

  • 28. Undertreatment of Pancreatic Cancer: The Intersection of Bias, Biology, and Geography.
    Torres MB; Dixon MEB; Gusani NJ
    Surg Oncol Clin N Am; 2022 Jan; 31(1):43-54. PubMed ID: 34776063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASO Author Reflections: The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer.
    Perri G; Katz MHG
    Ann Surg Oncol; 2020 Oct; 27(10):3948-3949. PubMed ID: 32358700
    [No Abstract]   [Full Text] [Related]  

  • 30. ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer may Reduce Microscopic Venous Invasion, Which is an Independent Prognostic Factor Associated with Liver Recurrence.
    Kubo H; Ohgi K; Sugiura T; Ashida R; Yamada M; Otsuka S; Yamazaki K; Todaka A; Sasaki K; Uesaka K
    Ann Surg Oncol; 2022 Aug; 29(8):5003-5004. PubMed ID: 35381935
    [No Abstract]   [Full Text] [Related]  

  • 31. Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma Are Mediated by Chemotherapy Utilization.
    Atkins JJ; Fiala MA; Wang-Gillam A; Wildes TM
    Pancreas; 2016 Aug; 45(7):e33-4. PubMed ID: 27400157
    [No Abstract]   [Full Text] [Related]  

  • 32. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.
    Singal V; Singal AK; Kuo YF
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):715-22. PubMed ID: 22246279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASO Author Reflections: A Standard Set of Value-Based Patient-Centered Outcomes for Pancreatic Carcinoma: An International Delphi Survey.
    Pessaux P; Cherkaoui Z
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):773-774. PubMed ID: 32495283
    [No Abstract]   [Full Text] [Related]  

  • 34. Diversity and Inclusion in Pancreatic Cancer Clinical Trials.
    Herremans KM; Riner AN; Winn RA; Trevino JG
    Gastroenterology; 2021 Dec; 161(6):1741-1746.e3. PubMed ID: 34416276
    [No Abstract]   [Full Text] [Related]  

  • 35. Pancreatic cancer disparities in African Americans.
    Khawja SN; Mohammed S; Silberfein EJ; Musher BL; Fisher WE; Van Buren G
    Pancreas; 2015 May; 44(4):522-7. PubMed ID: 25872128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of gender, race, and ethnicity with disparities in short-term adverse outcomes after pancreatic resection for cancer.
    Pastrana Del Valle J; Mahvi DA; Fairweather M; Wang J; Clancy TE; Ashley SW; Urman RD; Whang EE; Gold JS
    J Surg Oncol; 2022 Mar; 125(4):646-657. PubMed ID: 34786728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASO Author Reflections: Socioeconomic Disparities in Use of Surgery for Gastrointestinal Cancers Are Large and Impactful in Poor-Prognosis Cancers.
    Swords DS; Scaife CL
    Ann Surg Oncol; 2020 Feb; 27(2):342-343. PubMed ID: 31686347
    [No Abstract]   [Full Text] [Related]  

  • 38. We Must Change Our Approach to Racial Disparities in Prostate Cancer.
    Washington SL
    Eur Urol; 2022 Oct; 82(4):352-353. PubMed ID: 35934600
    [No Abstract]   [Full Text] [Related]  

  • 39. ASO Author Reflections: Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration.
    Del Valle JP; Gold JS
    Ann Surg Oncol; 2022 May; 29(5):3203-3204. PubMed ID: 35015185
    [No Abstract]   [Full Text] [Related]  

  • 40. ASO Author Reflections: Mitigating Survival Disparities in African American Women with Breast Cancer within the US Military Healthcare System-The Impact of Equivalent Care.
    Hueman MT; Shriver CD; Ellsworth RE
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):843-844. PubMed ID: 31659638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.